Q. I’ve been on simvastatin (80 mg) for several years. I’ve had serious problems with leg cramps and now my tendons are affected from my toes to my knees. Could the medication be responsible?
A. The FDA has just issued a warning about simvastatin (Zocor). The agency is concerned about muscle damage linked to high doses (80 mg) of this cholesterol-lowering medicine. Doctors are not supposed to prescribe this dose to new patients. Only people who have not experienced muscle problems after taking it for a year should continue on the 80 mg dose.
Even lower doses of simvastatin may cause side effects. One reader shared his story:

“I was started on simvastatin 20 mg, and by the third week I was in a lot of pain. My triceps and biceps hurt the worst, as though someone was ripping the muscles apart. I also had pain in my hips, legs and shoulders.”I stopped the simvastatin, but my blood tests showed elevated CPK (muscle breakdown) and decreased GFR (kidney functioning). Six months later, the labs show my GFR is normal, but my CPK is still mildly elevated. When I try to exercise, my muscles get sore quickly and the soreness lasts longer.”

Join Over 54,000 Subscribers at The People's Pharmacy

Each week we send two free email newsletters with breaking health news, prescription drug information, home remedies and a preview of our award-winning radio show. Join our mailing list and get the information you need to make confident choices about your health.

  1. JOSEPH T.
    Reply

    Also I am taking 10 mg of zolpidem at bedtime for a sleep aide. I have seen the paperwork that comes with it, that it can cause memory loss is that true? My memory loss is short term stuff. some days are better then others. thanks

What Do You Think?

Share your thoughts with others, but be mindful of protecting your own and others' privacy. Not all comments will be posted. Advice from web visitors is not a substitute for medical attention. Do not stop any medicine without checking with the prescriber. In posting a comment, you agree to our commenting policy and website terms and conditions.